Expression of concern
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
Paper Information
Record ID:
35388
Publication Date:
April 22, 2021
Retraction Date:
February 07, 2022
(3.8 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Front-Line Covid-19 Critical Care Alliance, Madison, WI
- Memphis VA Medical Center—University of Tennessee Health Science Center, Pulmonary, Critical Care, and Research Services, Memphis, TN
- University of Texas Health Science Center, Critical Care Service, Houston, TX
- Department of Medicine, Hackensack School of Medicine, Seton Hall, NJ
- Eastern Virginia Medical School, Division of Pulmonary and Critical Care, Norfolk, VA
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Wolters Kluwer - Lippincott Williams & Wilkins
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reason:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1097/MJT.0000000000001481Citations (163)
163
Total Citations105
Post-Retraction(64.4%)
58
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
8
Within 30 days
73
Within 1 year
9
After 2+ years
1232
Days since retraction (latest)
Electron Donor–Acceptor Capacity of Selected Pharmaceuticals against COVID-19
Ana Martı́nez
Antioxidants
Open Access
Published: Jun 2021
15 citations
15 citations
234 days before retraction
Comprehensive Cardiotoxicity Assessment of COVID-19 Treatments Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Shota Yanagida, Ayano Satsuka, Sayo Hayashi et al. (5 authors)
Toxicological Sciences
Open Access
Published: Jun 2021
17 citations
17 citations
236 days before retraction
Ivermectin for the Treatment of COVID-19 Disease: Too Good to Pass Up or Too Good to Be True?
Mark J. Siedner
Open Forum Infectious Diseases
Open Access
Published: Jun 2021
6 citations
6 citations
238 days before retraction
A Global Early Empirical Therapy Randomized Study Design for Ivermectin in SARS-CoV-2 Infection
Emmanuel Bhaskar
American Journal of Therapeutics
Published: May 2021
255 days before retraction
An Updated Systematic Review and Meta-Analysis of Mortality, Need for ICU admission, Use of Mechanical Ventilation, Adverse effects and other Clinical Outcomes of Ivermectin Treatment in COVID-19 Patients
Smruti Karale, Vikas Bansal, Janaki Makadia et al. (12 authors)
medRxiv (Cold Spring Harbor Laboratory)
Published: May 2021
15 citations
15 citations
279 days before retraction
The time to offer treatments for COVID-19
Binh Ngo, Paul E. Marik, Pierre Kory et al. (37 authors)
Expert Opinion on Investigational Drugs
Open Access
Published: Mar 2021
31 citations
31 citations
329 days before retraction
Identification and Development of Therapeutics for COVID-19.
Halie M. Rando, Nils Wellhausen, Soumita Ghosh et al. (23 authors)
PubMed
Published: Mar 2021
1 citation
1 citation
341 days before retraction
<scp>COVID</scp>‐19: immunopathology, pathophysiological mechanisms, and treatment options
Larissa E. van Eijk, Mathijs Binkhorst, Arno R. Bourgonje et al. (14 authors)
The Journal of Pathology
Open Access
Published: Feb 2021
130 citations
130 citations
355 days before retraction
Antiparasitic antibiotics from Japan
Kazuro Shiomi
Parasitology International
Published: Feb 2021
9 citations
9 citations
367 days before retraction
A scoping review of the pathophysiology of COVID-19
Paul E. Marik, José Iglesias, Joseph Varón et al. (4 authors)
International Journal of Immunopathology and Pharmacology
Open Access
Published: Jan 2021
65 citations
65 citations
402 days before retraction
SIT1 transporter as a potential novel target in treatment of COVID-19
Sabina Semiz
BioMolecular Concepts
Open Access
Published: Jan 2021
12 citations
12 citations
402 days before retraction
Efficacy of Generalized Face Masking Mandates
Alberto Boretti
Health Services Research and Managerial Epidemiology
Open Access
Published: Jan 2021
11 citations
11 citations
402 days before retraction
The History of Methylprednisolone, Ascorbic Acid, Thiamine, and Heparin Protocol and I-MASK+ Ivermectin Protocol for COVID-19
Mika Turkia
Cureus
Open Access
Published: Dec 2020
5 citations
5 citations
403 days before retraction
Quick Stats
Total Citations:
163
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025